Evidence map›Paper›PMID 38674148›Full record

ArticleInternational journal of molecular sciences2024

Change in Tissue Microbiome and Related Human Beta Defensin Levels Induced by Antibiotic Use in Bladder Carcinoma.

Ádám Monyók, Bassel Mansour, István Vadnay, Nóra Makra, Zsuzsanna A Dunai, Éva Nemes-Nikodém, Balázs Stercz, Dóra Szabó, Eszter Ostorházi

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ádám MonyókDepartment of Urology, Markhot Ferenc University Teaching Hospital, 3300 Eger, Hungary.
Bassel MansourDepartment of Urology, Markhot Ferenc University Teaching Hospital, 3300 Eger, Hungary.
István VadnayDepartment of Pathology, Markhot Ferenc University Teaching Hospital, 3300 Eger, Hungary.
Nóra MakraDepartment of Medical Microbiology, Semmelweis University, 1085 Budapest, Hungary.
Zsuzsanna A DunaiDepartment of Medical Microbiology, Semmelweis University, 1085 Budapest, Hungary.
Éva Nemes-NikodémDepartment of Medical Microbiology, Semmelweis University, 1085 Budapest, Hungary.
Balázs SterczDepartment of Medical Microbiology, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0002-9585-8397
Dóra SzabóDepartment of Medical Microbiology, Semmelweis University, 1085 Budapest, Hungary.
Eszter OstorháziDepartment of Medical Microbiology, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0002-9459-7316
Semmelweis University · HUJahn Ferenc Dél-Pesti Kórház és Rendelőintézet · HU

Funding

European Union's Horizon 2020 Antimicrobial Resistance Survaillance 952491-AmReSuSemmelweis University-Hungarian Research Network Human Microbiota Study Group No"0272"
6 · The paper itself

Abstract

It is now generally accepted that the success of antitumor therapy can be impaired by concurrent antibiotic therapy, the presence of certain bacteria, and elevated defensin levels around the tumor tissue. The aim of our current investigation was to identify the underlying changes in microbiome and defensin levels in the tumor tissue induced by different antibiotics, as well as the duration of this modification. The microbiome of the tumor tissues was significantly different from that of healthy volunteers. Comparing only the tumor samples, no significant difference was confirmed between the untreated group and the group treated with antibiotics more than 3 months earlier. However, antibiotic treatment within 3 months of analysis resulted in a significantly modified microbiome composition. Irrespective of whether Fosfomycin, Fluoroquinolone or Beta-lactam treatment was used, the abundance of

Indexed as

Anti-Bacterial Agentsbeta-DefensinsMicrobiotaUrinary Bladder NeoplasmsAgedbeta-LactamsFemaleFluoroquinolonesFosfomycinHumansMaleMiddle AgedAnti-Bacterial Agentsbeta-Defensinsbeta-LactamsFluoroquinolonesFosfomycinantibiotic treatmentbladder cancerhuman beta defensinstissue microbiome

Identifiers

PMID38674148
PMCPMC11050017
OpenAlexW4395010926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.